KERX
Keryx Biopharmaceuticals Inc
KERX
KERX
Delisted
KERX was delisted on the 12th of December, 2018.
130 hedge funds and large institutions have $312M invested in Keryx Biopharmaceuticals Inc in 2016 Q1 according to their latest regulatory filings, with 17 funds opening new positions, 49 increasing their positions, 40 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
130
Holders Change
+2
Holders Change %
+1.56%
% of All Funds
3.47%
Holding in Top 10
–
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-100%
% of All Funds
–
New
17
Increased
49
Reduced
40
Closed
15
Calls
$3.09M
Puts
$3.22M
Net Calls
-$133K
Net Calls Change
+$2.61M
Top Buyers
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$1.43M |
| 2 |
ACM
Abrams Capital Management
Boston,
Massachusetts
|
+$1.02M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$933K |
| 4 |
RA
Royce & Associates
New York
|
+$514K |
| 5 |
D.E. Shaw & Co
New York
|
+$481K |
Top Sellers
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$10.5M |
| 2 |
State Street
Boston,
Massachusetts
|
-$5.01M |
| 3 |
Franklin Resources
San Mateo,
California
|
-$4.22M |
| 4 |
CCP
Clough Capital Partners
Boston,
Massachusetts
|
-$3.89M |
| 5 |
CCM
Cadian Capital Management
New York
|
-$3.03M |
